Strength Seen in Ohr Pharmaceutical, Inc. (OHRP) Stock Shoots 22% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Ohr Pharmaceutical, Inc. ( OHRP ) was a big mover last session, as the company saw its shares surge 22% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $13.34 to $16.44 in the past one-month time frame.

The company has seen 1 positive revision in the past month, while the Zacks Consensus Estimate of a loss narrowed over the same period, suggesting that more solid trading could be ahead for Ohr Pharmaceutical. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Ohr Pharmaceutical currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Some other players in the healthcare industry include Alexion Pharmaceuticals, Inc. ( ALXN ), with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. ( ALIOF ) and Cambrex Corporation. ( CBM ) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>


ALEXION PHARMA (ALXN): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report


To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: ALIOF , ALXN , CBM , OHRP

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by